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Background: Several definitions have been used to assess rates of contrast-induced nephropathy (CIN) in patients undergoing percutaneous 
coronary intervention (PCI). Whether the definition influences observed rates of CIN is unclear.
Objectives: The Oxilan Registry was the first prospective analysis of the efficacy and safety of ioxilan (low-osmolar and low-viscosity contrast 
medium), including rates of CIN assessed by multiple definitions, in PCI.
Methods: From July 2006 to June 2007, consecutive patients undergoing PCI using ioxilan were enrolled. Serum creatinine (SCr) and estimated 
glomerular filtration rate (eGFR) were assessed at baseline and 3 to 5 days after PCI. CIN was defined as SCr increase ≥0.5 mg/dl, eGFR decrease 
≥25%, SCr increase ≥25%, or the composite.
Results: Of 400 patients (age 62 ± 11 years), 19% were women, 37% were diabetic, 22% were anemic, and 8% had a history of congestive 
heart failure. Baseline SCr was 1.12 ± 0.3 mg/dl and 24% had an eGFR <60 ml/min. CIN rates were 3.3% (SCr increase ≥0.5 mg/dl), 7.6% (eGFR 
decrease ≥25%), 10.2% (SCr increase ≥25%), and 10.5% (composite). Hospitalization was prolonged in 3.4% of patients with CIN and none 
required dialysis. There were no deaths or severe allergic reactions. Non-ST-elevation myocardial infarction and repeat revascularization each 
occurred in 0.8%.
Conclusions: In this unselected population undergoing PCI, CIN ranged in frequency from 3.3% to 10.5% depending on the definition used and 
was not associated with in-hospital mortality or substantial morbidity, such as dialysis. The wide variation in CIN and its lack of association with 
adverse outcomes underscore the need for a standardized, clinically relevant definition.
